Back

Glucose lowering drugs and cardiovascular outcome.

30 April 2017 (09:15 - 09:37)
Organised by:
Congress Presentation Part of: Hot topics in diabetes and heart failure co-morbidities (other) HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Professor Marc Pfeffer

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

3 More presentations in this session

Presentation thumbnail
Diabetes-related cardiomyopathy.
Professor P. Seferovic (Belgrade, RS)
Slides Video
Presentation thumbnail
Sudden cardiac death.
Professor P. Vardas (Heraklion, GR)
Slides Video
Presentation thumbnail
Revascularisation.
Professor S. Windecker (Bern, CH)
Slides Video

Access the full session

Session thumbnail
Hot topics in diabetes and heart failure

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

30 April 2017 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Glucose lowering drugs or strategies, major adverse cardiovascular events and heart failure outcomes, and association with weight loss - meta-analysis of large cardiovascular outcome trials
2 September 2019
thumbnail
Webinar
EAPC Webinar: Type 2 Diabetes and cardiovascular risk
12 March 2019
thumbnail
Congress Session
Young Investigator Award (YIA) Basic Science
17 May 2025
thumbnail
Congress Presentation
Sodium-glucose cotransporter-2 inhibitors and their combination with glucagon like peptide-1 receptor agonists improve endothelial glycocalyx and arterial stiffness in type-2 diabetes
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources